Clinical trial
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in…
NCT00307255 · UNC Lineberger Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00307255 |
|---|---|
| Title | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors |
| Official title | Phase I Trial of Abraxane in Combination With Gemcitabine in Patients With Solid Tumors |
| Lead sponsor | UNC Lineberger Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | gemcitabine hydrochloride, paclitaxel albumin-stabilized nanoparticle formulation |
| Enrollment | 18 |
| Start date | Aug 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Oct 1, 2008 |
| First posted | Mar 27, 2006 |
| Last update posted | Apr 4, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: